soul trial oral semaglutide cardiovascular outcomes results 2025 Frontiers The SOUL trial (Semaglutide Cardiovascular
Description
GLP-1 receptor agonists have been shown to shift macrophage polarization toward the M2 phenotype, the anti-inflammatory direction
With so many potential benefits, its understandable to have questions about GLP-1 drugs, including where they came from and how they work
Personalized Care Tailored to You Your journey is unique, and so is our care
The slowed digestion also helps decrease blood sugar spikes
With long-term GLP-1 use, ongoing supplementation can be beneficial
Who can you turn in your unit for this
